Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

THEMIS MEDICARE LTD. - 530199 - Outcome Of Board Meeting Held On June 08, 2020

 The Board of Directors at its meeting held today, considered and approved the following matters: 1. Approved the Audited Standalone and Consolidated financial results for the Quarter and Year ended 31st March, 2020. A copy of Audited Standalone and Consolidated Financial Results for the Quarter and Year ended 31st March, 2020 is enclosed herewith. (Annexure I) 2. Recommended dividend for Financial Year ended 31.03.2020 of Rs. 1.75/- (Re One Paise Seventy five only) per equity share having face value of Rs.10/- each, aggregating to Rs. 160.79 lacs. The payment is subject to the approval of shareholders at the ensuing AGM 3. Considered the appointment of M/s. B.J. D. Nanabhoy & Co., Cost Accountant as the Cost Auditors of the Company for the FY 2020-21. 4. Appointed Mr. Shirish Shetye of M/s. Shirish Shetye & Associates, Practicing Company Secretaries, as the Scrutinizer for conducting E-Voting and Poll at the 50thAnnual General Meeting.
08-06-2020
Bigul

THEMIS MEDICARE LTD. - 530199 - Board recommends Dividend

 Themis Medicare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 08, 2020, inter alia, has recommended dividend for Financial Year ended March 31, 2020 of Rs. 1.75/- (Re One Paise Seventy five only) per equity share having face value of Rs. 10/- each, aggregating to Rs. 160.79 lacs. The payment is subject to the approval of shareholders at the ensuing AGM.
08-06-2020
Bigul

THEMIS MEDICARE LTD. - 530199 - Results - Financial Results For The Quarter And Year Ended March 31,2020

 1.Approved the Audited Standalone and Consolidated financial results for the Quarter and Year ended 31st March, 2020. A copy of Audited Standalone and Consolidated Financial Results for the Quarter and Year ended 31st March, 2020 is enclosed herewith. (Annexure I) 2.Recommended dividend for Financial Year ended 31.03.2020 of Rs. 1.75/- (Re One Paise Seventy five only) per equity share having face value of Rs.10/- each, aggregating to Rs. 160.79 lacs. The payment is subject to the approval of shareholders at the ensuing AGM 3.Considered the appointment of M/s. B.J. D. Nanabhoy & Co., Cost Accountant as the Cost Auditors of the Company for the FY 2020-21. 4.Appointed Mr. Shirish Shetye of M/s. Shirish Shetye & Associates, Practicing Company Secretaries, as the Scrutinizer for conducting E-Voting and Poll at the 50th Annual General Meeting.
08-06-2020
Bigul

THEMIS MEDICARE LTD. - 530199 - Board Meeting Intimation for Consider Audited Financial Results And Recommending Dividend If Any On The Equity Shares Of The Company For The Financial Year 2019-20 On Monday 08.06.2020

 THEMIS MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/06/2020 ,inter alia, to consider and approve 1. To consider the Audited Financial Results for the Quarter/Year ended on 31st March, 2020. 2. To consider recommending Dividend if any on the equity shares of the Company for the financial year 2019-20,
02-06-2020
Bigul

THEMIS MEDICARE LTD. - 530199 - Compliances - Compliance Certificate - Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended On March 31, 2020.

 Compliance Certificate - Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended on March 31, 2020.
26-05-2020
Bigul

Coronavirus: How Serum Institute could be world's door to COVID-19 vaccine

 Serum Institute has partnered with U.S. biotech firm Codagenix, its U.S. rival Novavax and Austria's Themis to potentially manufacture three COVID-19 vaccine candidates that are still in development
23-05-2020
Bigul

THEMIS MEDICARE LTD. - 530199 - Compliances- Compliance Certificate Under Regulation 40(9) Of The SEBI (LODR) Regulations, 2015 For The Half Year Ended 31St March, 2020

 Enclosed herewith please find Compliance Certificate issued by M/s. V. Laxman & Co Practicing Company Secretaries for the half year ended 31st March, 2020 in terms of Regulation 40(9) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. This may be taken as compliance under Regulation 40(9) of the Listing Regulations.
22-05-2020
Bigul

THEMIS MEDICARE LTD. - 530199 - Shareholding for the Period Ended March 31, 2020

 Themis Medicare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here
15-05-2020
Bigul

THEMIS MEDICARE LTD. - 530199 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 We are enclosing herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2020 received from Link lntime India Pvt. Ltd., Registrar and Share Transfer Agent of our Company. This is for your information and record.
13-05-2020
Bigul

THEMIS MEDICARE LTD. - 530199 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 We are enclosing herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2020 received from Link lntime India Pvt. Ltd., Registrar and Share Transfer Agent of our Company. This is for your information and record.
13-05-2020
Next Page
Close

Let's Open Free Demat Account